HCV-IN-38

HCV-IN-38 is a potent and selective oral inhibitor of hepatitis C virus (HCV), demonstrating high antiviral activity (EC50 = 15 nM) and a favorable selectivity index (SI = 431) . It exhibits a promising safety profile and pharmacokinetics, supporting its use in both in vitro virology studies and in vivo preclinical research for HCV drug discovery.